1007455-25-5 Usage
Uses
Used in Pharmaceutical Industry:
1H-Isoindol-1-one, 5-fluoro-2,3-dihydro-6-hydroxyis used as a gastric proton pump inhibitor for its ability to reduce gastric acid secretion. This application is particularly relevant for treating disorders such as gastroesophageal reflux disease and peptic ulcers, where the inhibition of gastric acid can provide relief from related symptoms.
1H-Isoindol-1-one, 5-fluoro-2,3-dihydro-6-hydroxy-'s unique structure and properties make it a valuable asset in the development of new treatments for acid-related disorders, potentially offering more effective and targeted therapies for patients suffering from these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 1007455-25-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,4,5 and 5 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1007455-25:
(9*1)+(8*0)+(7*0)+(6*7)+(5*4)+(4*5)+(3*5)+(2*2)+(1*5)=115
115 % 10 = 5
So 1007455-25-5 is a valid CAS Registry Number.
InChI:InChI=1S/C8H6FNO2/c9-6-1-4-3-10-8(12)5(4)2-7(6)11/h1-2,11H,3H2,(H,10,12)
1007455-25-5Relevant academic research and scientific papers
Synthesis of methyl-, fluoro-, and chloro-substituted 6-hydroxyisoindolin-1-ones
Powers, James J.,Favor, David A.,Rankin, Trent,Sharma, Rashmi,Pandit, Chetan,Jeganathan, Azhwarsamy,Maiti, Samarendra N.
supporting information; experimental part, p. 1267 - 1269 (2009/09/05)
The synthesis of a series of methyl-, fluoro-, and chloro-substituted 6-hydroxyisoindolin-1-ones is described.
ISOINDOLE DERIVATIVES
-
Page/Page column 29; 30, (2010/11/30)
This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, a process of making these compounds, pharmaceutical compositions containing one or more of these compounds or their salts, and their use for the treatment of schizophrenia, bipolar disorder, or other central nervous system disorders.